Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 4/20 | 0.60 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.59 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL769213 | 0.95 | CYP2D6 (0.62) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| SCHEMBL769130 | 0.95 | ADRA1A (0.62) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| Hydrochloric Acid SCHEMBL10749411 | 0.94 | CYP2D6 (0.63) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| Hydrochloric Acid SCHEMBL10751218 | 0.94 | CYP2D6 (0.63) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| Hydrochloric Acid SCHEMBL9814104 | 0.87 | CYP2D6 (0.52) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| SCHEMBL10855884 | 0.80 | NISCH (0.47) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| SCHEMBL10854235 | 0.80 | NISCH (0.47) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| Hydrochloric Acid SCHEMBL10749865 | 0.80 | CYP2D6 (0.59) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| SCHEMBL769057 | 0.79 | ADRA1A (0.67) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 | |
| SCHEMBL769780 | 0.79 | ADRA1A (0.67) | ADRA1AADRA2ACYP2D6HTR1AOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1981499-A1 | USE OF 2-IMIDAZOLES FOR THE TREATMENT OF CNS DISORDERS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-10-22 | — | — | EP | claimed |
| WO-2007085558-A1 | USE OF 2-IMIDAZOLES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-02 | — | — | WO | claimed |
| EP-1981499-A1 | USE OF 2-IMIDAZOLES FOR THE TREATMENT OF CNS DISORDERS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-10-22 | — | — | EP | disclosed |
| WO-2007085558-A1 | USE OF 2-IMIDAZOLES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-02 | — | — | WO | disclosed |